Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes
Tomoko Nakanishi, Vincenzo Forgetta, Tomohiro Handa, Toyohiro Hirai, Vincent Mooser, G. Mark Lathrop, William O.C.M. Cookson, J. Brent Richards
Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tomoko Nakanishi, Vincenzo Forgetta, Tomohiro Handa, Toyohiro Hirai, Vincent Mooser, G. Mark Lathrop, William O.C.M. Cookson, J. Brent Richards. The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes. Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Alpha-1 antitrypsin deficiency – a potentially fatal disease
Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases
Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency.
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Monitoring disease progression in severe Alpha1 antitrypsin deficiency
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Estimates of the prevalence of alpha-1 antitrypsin deficiency PI*S and PI*Z alleles and the numbers at risk in Europe
Source: Eur Respir J 2005; 26: Suppl. 49, 219s
Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency
Source: Eur Respir J 2003; 22: Suppl. 45, 384s
Alpha-1 antitrypsin deficiency and pulmonary morbidity in patients with primary immunodeficiency disease: A single center experience
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
The patient perspective of alpha-1 antitrypsin deficiency: disease burden and unmet needs
Source: Breathe, 17 (1) 200340; 10.1183/20734735.0340-2020
COPD in individuals with the PiMZ alpha-1 antitrypsin genotype
Source: Eur Respir Rev, 26 (146) 170068; 10.1183/16000617.0068-2017
A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Polymorphisms of the beta adrenoceptor are associated with severity of disease, but not disease susceptibility, in subjects with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 378s
Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Prevalence of mutations in the alpha 1 antitrypsin gene in patients with pulmonary emphysema
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions